Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
Clinical trial NCT04750226 · COMPLETED
Trial details
- NCT number
- NCT04750226
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-18
- Primary completion
- 2026-04-27
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.